CA2980975C - Compositions de sarna c/ebp alpha et methodes d'utilisation - Google Patents

Compositions de sarna c/ebp alpha et methodes d'utilisation

Info

Publication number
CA2980975C
CA2980975C CA2980975A CA2980975A CA2980975C CA 2980975 C CA2980975 C CA 2980975C CA 2980975 A CA2980975 A CA 2980975A CA 2980975 A CA2980975 A CA 2980975A CA 2980975 C CA2980975 C CA 2980975C
Authority
CA
Canada
Prior art keywords
sarna
pharmaceutical composition
ebpa
cell
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2980975A
Other languages
English (en)
Other versions
CA2980975A1 (fr
Inventor
Andreas Wagner
Robert Habib
Hans E. Huber
Pal SAETROM
Endre Bakken Stovner
Markus Hossbach
Monika KRAMPERT
Hans-Peter Vornlocher
Original Assignee
Mina Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mina Therapeutics Ltd filed Critical Mina Therapeutics Ltd
Priority claimed from PCT/GB2016/051117 external-priority patent/WO2016170349A1/fr
Publication of CA2980975A1 publication Critical patent/CA2980975A1/fr
Application granted granted Critical
Publication of CA2980975C publication Critical patent/CA2980975C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne un petit ARN activateur (saRNA) ciblant un transcrit C/EBPa, et des compositions thérapeutiques contenant ledit saRNA. L'invention concerne également des méthodes d'utilisation desdites compositions thérapeutiques.
CA2980975A 2015-04-22 2016-04-21 Compositions de sarna c/ebp alpha et methodes d'utilisation Active CA2980975C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562150889P 2015-04-22 2015-04-22
US62/150,889 2015-04-22
US201562235778P 2015-10-01 2015-10-01
US62/235,778 2015-10-01
US201662308521P 2016-03-15 2016-03-15
US62/308,521 2016-03-15
PCT/GB2016/051117 WO2016170349A1 (fr) 2015-04-22 2016-04-21 Compositions de sarna c/ebp alpha et méthodes d'utilisation

Publications (2)

Publication Number Publication Date
CA2980975A1 CA2980975A1 (fr) 2016-10-27
CA2980975C true CA2980975C (fr) 2025-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
AU2019210578B2 (en) C/EBP alpha saRNA compositions and methods of use
US11965163B2 (en) HNF4a saRNA compositions and methods of use
JP6621409B2 (ja) Ｃ／ＥＢＰα小分子活性化ＲＮＡ組成物
CA2980975C (fr) Compositions de sarna c/ebp alpha et methodes d'utilisation
JP7525578B2 (ja) Ｃ／ＥＢＰα小分子活性化ＲＮＡ組成物